BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2937452)

  • 1. Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen.
    Váradi A; Scheraga HA
    Biochemistry; 1986 Feb; 25(3):519-28. PubMed ID: 2937452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen.
    Horwitz BH; Váradi A; Scheraga HA
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):5980-4. PubMed ID: 6592597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
    Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
    J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
    Ferguson EW; Fretto LJ; McKee PA
    J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of a fibrin polymerization site.
    Olexa SA; Budzynski AZ
    J Biol Chem; 1981 Apr; 256(7):3544-9. PubMed ID: 6451630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
    Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
    Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen.
    Southan C; Thompson E; Panico M; Etienne T; Morris HR; Lane DA
    J Biol Chem; 1985 Oct; 260(24):13095-101. PubMed ID: 2932434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
    Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
    J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
    Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence.
    Dang CV; Ebert RF; Bell WR
    J Biol Chem; 1985 Aug; 260(17):9713-9. PubMed ID: 3160702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the cross-linking site of GPRVVERHK in the gamma-chain of human fibrinogen.
    Cierniewski CS; Budzynski AZ
    Eur J Biochem; 1993 Dec; 218(2):321-5. PubMed ID: 8269920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis.
    Yoshida N; Hirata H; Morigami Y; Imaoka S; Matsuda M; Yamazumi K; Asakura S
    J Biol Chem; 1992 Feb; 267(4):2753-9. PubMed ID: 1733971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
    Cierniewski CS; Kloczewiak M; Budzynski AZ
    J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of divalent cations in the plasmin degradation of fibrinogen.
    Dang CV; Bell WR; Ebert RF; Starksen NF
    Arch Biochem Biophys; 1985 May; 238(2):452-7. PubMed ID: 3158281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
    Krajewski T; Nowak P; Cierniewski C
    Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
    Yamazumi K; Terukina S; Onohara S; Matsuda M
    Thromb Haemost; 1988 Dec; 60(3):476-80. PubMed ID: 2976995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2.
    Sahni A; Francis CW
    J Thromb Haemost; 2003 Jun; 1(6):1271-7. PubMed ID: 12871330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in electrophoretic mobility and plasmic digestion profile between four recombinant fibrinogens, gamma 308K, gamma 308I, gamma 308A, and wild type (gamma 308N).
    Okumura N; Terasawa F; Fujita K; Tozuka M; Ota H; Katsuyama T
    Electrophoresis; 2000 Jul; 21(12):2309-15. PubMed ID: 10939439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.